Cibus (NASDAQ:CBUS) Stock Rating Raised to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Cibus (NASDAQ:CBUS) from a sell rating to a hold rating in a research report sent to investors on Saturday,Wall Street Zen reports.

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Cibus in a research note on Friday, September 25th. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $9.00.

Cibus Stock Performance

Shares of NASDAQ:CBUS opened at $1.71 on Friday. The business’s fifty day moving average price is $1.69 and its two-hundred day moving average price is $1.66. The stock has a market cap of $130.70 million, a PE ratio of -1.04 and a beta of 1.57. Cibus has a one year low of $1.09 and a one year high of $4.19.

Cibus (NASDAQ:CBUS) last released its quarterly earnings results on Thursday, August 13th. The company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.10). Cibus had a negative return on equity of 287.03% and a negative net margin of 2,258.89%.The company had revenue of $0.99 million during the quarter, compared to analyst estimates of $1.70 million. As a group, equities research analysts predict that Cibus will post -1.13 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of CBUS. Dimensional Fund Advisors LP acquired a new stake in shares of Cibus in the first quarter worth approximately $33,000. Renaissance Technologies LLC increased its position in Cibus by 42.5% during the first quarter. Renaissance Technologies LLC now owns 98,900 shares of the company’s stock worth $196,000 after purchasing an additional 29,500 shares during the last quarter. Rockland Trust Co. acquired a new position in Cibus during the second quarter worth approximately $41,000. OMERS ADMINISTRATION Corp purchased a new position in Cibus during the first quarter worth approximately $66,000. Finally, Bank of America Corp DE raised its stake in Cibus by 324.2% during the first quarter. Bank of America Corp DE now owns 74,358 shares of the company’s stock worth $147,000 after purchasing an additional 56,830 shares during the period. 33.81% of the stock is currently owned by institutional investors and hedge funds.

Cibus Company Profile

Cibus, Inc is an agricultural biotechnology company that develops gene-edited traits for crops. Its technology is designed to make targeted changes to plant genetics without introducing foreign DNA, with the goal of improving crop performance, productivity and sustainability.

The company’s proprietary Rapid Trait Development System (RTDS) platform is used to develop traits for the global seed industry. Cibus has focused on crops including canola, soybean and rice, pursuing applications such as improved disease resistance, herbicide tolerance, reduced pod shatter and other traits intended to support farmers and seed companies.

Founded in 2001, Cibus became a publicly traded company following its 2023 merger with Calyxt, Inc The company is headquartered in San Diego, California, and works with agricultural and seed-industry partners to advance and commercialize gene-edited crop traits.